Envista Holdings Corporation (NVST)

Market Cap	3.20B
Revenue (ttm)	2.50B
Net Income (ttm)	-1.12B
Shares Out	169.49M
EPS (ttm)	-6.54
PE Ratio	n/a
Forward PE	17.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,199,927
Open	18.75
Previous Close	18.61
Day's Range	18.47 - 19.12
52-Week Range	14.22 - 23.00
Beta	1.00
Analysts	Buy
Price Target	20.55 (+8.79%)
Earnings Date	Aug 6, 2025

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 18, 2019
• Employees: 12,300
• Stock Exchange: NYSE
• Ticker Symbol: NVST
• Website: https://envistaco.com

Financial Performance

In 2024, Envista Holdings's revenue was $2.51 billion, a decrease of -2.18% compared to the previous year's $2.57 billion. Losses were -$1.12 billion, 1016.4% more than in 2023.

Analyst Forecast

According to 12 analysts, the average rating for NVST stock is "Buy." The 12-month stock price forecast is $20.55, which is an increase of 8.79% from the latest price.

Price Target

$20.55

(8.79% upside)

Analyst Consensus: Buy